Nuveen’s Endologix Inc ELGX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q4
Sell
-18,482
Closed -$2.37M 1604
2016
Q3
$2.37M Buy
18,482
+8,359
+83% +$1.07M 0.01% 718
2016
Q2
$1.26M Buy
+10,123
New +$1.16M 0.01% 935
2015
Q3
Sell
-17,674
Closed -$2.71K 1642
2015
Q2
$2.71K Sell
17,674
-7,318
-29% -$1.21M 0.01% 699
2015
Q1
$4.27M Sell
24,992
-12,164
-33% -$1.84M 0.02% 562
2014
Q4
$5.68M Buy
37,156
+12,992
+54% +$1.62M 0.03% 513
2014
Q3
$2.56M Sell
24,164
-1,834
-7% -$256K 0.02% 720
2014
Q2
$3.95M Sell
25,998
-5,239
-17% -$697K 0.02% 601
2014
Q1
$4.02M Buy
31,237
+22,405
+254% +$3.48M 0.02% 587
2013
Q4
$1.54M Buy
+8,832
New +$1.52M 0.01% 885

Other funds holding ELGX

Nuveen's ELGX Position: Q4 2016 in Review

Nuveen sold out of Endologix Inc (ELGX) in Q4 2016, closing a stake of 18,482 shares — an estimated $2.37M sold.

Nuveen first reported a position in ELGX in Q4 2013 and held it in 9 quarters. The position peaked at $5.68M in Q4 2014. 140 funds tracked by Wall St. Rank hold ELGX as of Q4 2016.

  • Nuveen reported no remaining Endologix Inc position as of Q4 2016 after selling out during the quarter.
  • Nuveen sold 18,482 Endologix Inc shares in Q4 2016, an estimated $2.37M.
  • Nuveen first reported a position in Endologix Inc in Q4 2013 and held it in 9 quarters.
  • Nuveen's Endologix Inc position peaked at $5.68M in Q4 2014.
  • 140 funds tracked by Wall St. Rank held Endologix Inc as of Q4 2016.

Based on Nuveen's 13F filing for Q4 2016, filed 14 Feb 2017.